Title: A Rare Case of Biotinidase Deficiency

Authors: Dr Sunil Kumar Agarwalla, Dr Soumya Ranjan Samal, Dr Rajesh Kumar Rout, Swastikranjan Jena

 DOI: https://dx.doi.org/10.18535/jmscr/v9i8.21

Abstract

Biotinidase is an autosomal recessive disorder caused due to deficiency of enzyme Biotinidase.  Most of the patients presented in infancy with neurodevelopmental regression, hypotonia, alopecia, dermatological and neurological manifestations. The clinical response to biotin is dramatic with seizure control in all most all patients .Biotinidase deficiency is a treatable condition, should be thought of any child presenting with neuro-regression , seizure and with dermatological manifestations such as alopecia and skin rashes.

Here we are present a 11 month old male infant who presented to the paediatrics emergency with multifocal seizure , neuro – regression ,  who on examination found to have alopecia and loss of eye brow and eye lashes without any neuro-cutanous manifestation . This on investigation found out to be Biotinidase deficiency.  We are reporting this case because of its rarity where strong clinical suspicion and investigation tools helped in timely diagnosis and intervention.

Keywords: Biotinidse deficiency, Seizure, Alopecia, Infancy.

References

  1. Wolf B, Grier RE, Allen RJ, Goodman SI, Kien CL. Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. ClinChimActa. 1983;131(3):273–281. doi:10.1016/0009-8981(83)90096-7
  2. Wolf B. Biotinidase deficiency: "if you have to have an inherited metabolic disease, this is the one to have". Genet Med 2012;14:565-75. [PUBMED]
  3. Mastrangelo M. Actual insights into treatable inborn errors of metabolism causing epilepsy. J Pediatr Neurosci. 2018; 13(1):13–23. doi:10.4103/JPN.JPN_160_16
  4. Haagerup A, Andersen JB, Blichfeldt S, Christensen MF. Biotinidase deficiency: Two cases of very early presentation. Dev Med Child Neurol 1997;39:832-5. [PUBMED]
  5. Karaca M, Özgül RK, Ö Ü, et al. Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screening. Eur J Pediatr. 2015;174(8):1077–1084. doi:10.1007/s00431-015-2509-5
  6. Weber P, Scholl S, Baumgartner ER. Outcome in patients with profound biotinidase deficiency: Relevance of newborn screening. Dev Med Child Neurol 2004;46:481-4. [PUBMED]
  7. Micó SI, Jiménez RD, Salcedo EM, Martínez HA, Mira AP, Fernández CC. Epilepsy in Biotinidase deficiency after biotin treatment. JIMD Rep 2012;4:75-8.
  8. Venkataraman V, Balaji P, Panigrahi D, Jamal R. Biotinidase deficiency in childhood. Neurol India. 2013;61(4):411–413. doi:10.4103/0028-3886.117614
  9. Canda E, Yazici H, Er E, et al. Single center experience of biotinidase deficiency: 259 patients and six novel mutations. J Pediatr Endocrinol Metab. 2018; 31(8):917–926. doi:10.1515/jpem-2018-0148.
  10. Salbert BA, Astruc J, Wolf B. Ophthalmologic findings in biotinidase deficiency. Ophthalmologica. 1993;206 (4):177–181. doi:10.1159/000310387

Corresponding Author

Dr Rajesh Kumar Rout

JR Dept. of Pediatrics, M.K.C.G. Medical College